These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38102564)

  • 21. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
    McKenzie YA; Thompson J; Gulia P; Lomer MC;
    J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
    Ljótsson B; Jones M; Talley NJ; Kjellström L; Agréus L; Andreasson A
    United European Gastroenterol J; 2020 Apr; 8(3):284-292. PubMed ID: 32213021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irritable bowel syndrome: Factors of importance for disease-specific quality of life.
    Melchior C; Colomier E; Trindade IA; Khadija M; Hreinsson JP; Törnblom H; Simrén M
    United European Gastroenterol J; 2022 Sep; 10(7):754-764. PubMed ID: 35830193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Li X; Li B; Zhang J; Chen T; Wu H; Shi X; Ma J; Qin J; Tang X; Wang F
    Medicine (Baltimore); 2021 Jan; 100(4):e24361. PubMed ID: 33530231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China.
    Lv CL; Song GQ; Liu J; Wang W; Huang YZ; Wang B; Tian JS; Yin MQ; Yu Y
    World J Gastroenterol; 2023 Nov; 29(41):5657-5667. PubMed ID: 38077156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.
    Le Nevé B; Posserud I; Böhn L; Guyonnet D; Rondeau P; Tillisch K; Naliboff B; Mayer EA; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):786-95. PubMed ID: 23588235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta-analysis.
    Chong RIH; Yaow CYL; Loh CYL; Teoh SE; Masuda Y; Ng WK; Lim YL; Ng QX
    J Gastroenterol Hepatol; 2022 Jun; 37(6):993-1003. PubMed ID: 35396764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome.
    Le Nevé B; Brazeilles R; Derrien M; Tap J; Guyonnet D; Ohman L; Törnblom H; Simrén M
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):226-33.e1-3. PubMed ID: 26492847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.
    Black CJ; Ng CE; Goodoory VC; Ford AC
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):386-396.e10. PubMed ID: 36858142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome.
    Rurgo S; Vaino V; Andreozzi M; Pagliaro M; Senneca P; Di Giorgio G; Efficie E; Sarnelli G; Pesce M
    J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):665-671. PubMed ID: 35659327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.
    Goo YA; Cain K; Jarrett M; Smith L; Voss J; Tolentino E; Tsuji J; Tsai YS; Panchaud A; Goodlett DR; Shulman RJ; Heitkemper M
    J Proteome Res; 2012 Dec; 11(12):5650-62. PubMed ID: 22998556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
    Duan R; Zhu S; Wang B; Duan L
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00012. PubMed ID: 30829919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.